F1 antigenaemia in bubonic plague patients, a marker of gravity and efficacy of therapy

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 92, Issue 5, 1998, Pages 572-573

  Chanteau, S ^a   Rabarijaona, L ^a   O'Brien, T ^b   Rahalison, L ^a   Hager, J ^b   Boisier, P ^a   Burans, J ^c   Rasolomaharo, M ^d  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b NAVAL MEDICAL RESEARCH INSTITUTE   (United States)

^c US Naval Medical Research Unit No 2 Jakarta   (Indonesia)

^d Androva Hospital   (Madagascar)

Author keywords

Plague; Yersina pestis

Indexed keywords

ANTIGEN; COTRIMOXAZOLE; MARKER; STREPTOMYCIN;

ARTICLE; BACTERIUM CULTURE; DISEASE SEVERITY; DRUG EFFICACY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MADAGASCAR; MAJOR CLINICAL STUDY; ORAL DRUG ADMINISTRATION; PLAGUE; PROGNOSIS; YERSINIA PESTIS;

BACTERIA (MICROORGANISMS); YERSINIA PESTIS;

EID: 0031734380     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(98)90923-3     Document Type: Article

References (9)

1. Boisier, P., Rasolomaharo, M., Ranaivoson, G., Rasoamanana, B., Rakoto, L., Andrianirina, Z., Andriamahefazafy, B. & Chanteau, S. (1997). Urban epidemic of bubonic plague in Mahjunga, Madagascar: epidemiological aspects. Tropical Medicine and International Health, 2, 422-427.
2. Brubaker, R. R. (1972). The genus Yersinia: biochemistry and genetics of virulence. Current Topics in Microbiology and Immunology, 57, 111-158.
3. Champetier de Ribes, G., Rasoamanana, B., Randriambelosoa, J., Rakoto, L., Rabeson, D. & Chanteau, S. (1997). La peste à Madagascar: données épidémiologiques de 1989 à 1995 et programme national de lutte. Cahiers de Santé de l'AUPELF UREF, 7, 53-60.
4. Chanteau, S., Ratsifasomanana, L., Rasomanana, B., Rahilson, L., Randriambelosoa, J., Roux, J. & Rabeson, D. (1998). Plague a re-emerging disease in Madagascar. Emerging Diseases, 4, 101-104.
5. Rasoamanana, B., Leroy, F., Boisier, P., Rasdolomaharo, M., Buchy, P., Carniel, E. & Chanteau, S. (1997). Field evaluation of an immunoglobulin G anti-F1 ELISA assay for serodiagnosis of human plague in Madagascar. Clinical and Diagnostic Laboratory Immunology, 4, 587-591.
6. WHO (1970). Expert Committee on Plague. Fourth Report. Geneva: World Health Organization, Technical Report Series, no. 447.
7. WHO (1996). Human plague in 1994. Weekly Epidemiological Record, 71, 165-172.
8. Williams, J. E., Gentry, M. K., Braden, C. A., Leister, F. & Yolken, R. H. (1984). Use of enzyme-linked immunosorbent assay to measure antigenaemia during acute plague. Bulletin of the World Health Organization, 62, 463-466.
9. Williams, J. E., Arntzen, L., Tyndal, G. L. & Isaacson, M. (1986). Application of enzyme immunoassays for the confirmation of clinically suspect plague in Namibia. Bulletin of the World Health Organization, 64, 745-752.